These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17703723)

  • 1. [Polymer and oligomer based doxorubicin carriers].
    Kik K; Lwow F; Szmigiero L
    Polim Med; 2007; 37(1):47-55. PubMed ID: 17703723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
    Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F
    J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.
    Tahover E; Patil YP; Gabizon AA
    Anticancer Drugs; 2015 Mar; 26(3):241-58. PubMed ID: 25415656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy.
    Chiang YT; Lo CL
    Biomaterials; 2014 Jul; 35(20):5414-5424. PubMed ID: 24709521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.
    Koziolová E; Kostka L; Kotrchová L; Šubr V; Konefal R; Nottelet B; Etrych T
    Biomacromolecules; 2018 Oct; 19(10):4003-4013. PubMed ID: 30180562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated liposomal doxorubicin in ovarian cancer.
    Green AE; Rose PG
    Int J Nanomedicine; 2006; 1(3):229-39. PubMed ID: 17717964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
    Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
    Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive targeting of doxorubicin with polymer coated liposomes in tumor bearing rats.
    Takeuchi H; Kojima H; Yamamoto H; Kawashima Y
    Biol Pharm Bull; 2001 Jul; 24(7):795-9. PubMed ID: 11456120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-coated long-circulating microparticulate pharmaceuticals.
    Torchilin VP
    J Microencapsul; 1998; 15(1):1-19. PubMed ID: 9463803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel drug delivery system using thermoreversible gelation polymer for malignant glioma.
    Arai T; Joki T; Akiyama M; Agawa M; Mori Y; Yoshioka H; Abe T
    J Neurooncol; 2006 Mar; 77(1):9-15. PubMed ID: 16292493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
    Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A
    Clin Cancer Res; 1998 Feb; 4(2):499-505. PubMed ID: 9516942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
    Arai T; Benny O; Joki T; Menon LG; Machluf M; Abe T; Carroll RS; Black PM
    Anticancer Res; 2010 Apr; 30(4):1057-64. PubMed ID: 20530409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?
    Theodoulou M; Hudis C
    Cancer; 2004 May; 100(10):2052-63. PubMed ID: 15139046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.